Cited by 1,772Liver Disease Diagnosis and TreatmentLiver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Molecular mediators of hepatic steatosis and liver injury

Open access

Browning, Jeffrey D., Horton, Jay D.·2004·Journal of Clinical Investigation

DOI 10.1172/jci200422422PMC PMC449757

Open this paper in CoChat — free account Open PDF

Abstract

Nonstandard abbreviations used: acetyl-CoA carboxylase (ACC); AMP-activated protein kinase (AMPK); basic helix-loop-helix-leucine zipper (bHLH-Zip); carbohydrate response element binding protein (ChREBP); carnitine palmitoyl transferase-1 (CPT-1); diethylaminoethoxyhexestrol (DEAEH); liver function test (LFT); liver-type pyruvate kinase (L-PK); malondialdehyde (MDA); mitochondrial respiratory chain (MRC); nonalcoholic fatty-liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); polyunsaturated fatty acid (PUFA); reactive oxygen species (ROS); stearoyl-CoA desaturase (SCD); trans-4-hydroxy-2-nonenal (HNE). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci200422422

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citation
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166

Show all 82 references

Research works printed but not linked: 1

Garcia-Ruiz, 1995, Mol. Pharmacol., 48, 825

Sorted by citations

Items 501–600 of 1,005

Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
Greenstein, A. W., Majumdar, N., Yang, P., Subbaiah, P. V., Kineman, R. D., & Córdoba‐Chacón, J. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0447 · Cited by 80
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
Papazyan, R., Sun, Z., Kim, Y. H., Titchenell, P. M., Hill, D. A., Lu, W., Damle, M., Wan, M., Zhang, Y., Briggs, E. R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.012 · Cited by 80
IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
Gao, Y., Liu, Y., Yang, M., Guo, X., Zhang, M., Li, H., Li, J., & Zhao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9259 · Cited by 79
Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease
Donates, Y. C., Lacraz, G., Ghobadi, F., Rakotoarivelo, V., Orkhis, S., Mayhue, M., Chen, Y.-G., Rola‐Pleszczynski, M., Menéndez, A., Ilangumaran, S., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.020 · Cited by 79
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
Tan, P., Li, J., Qin, X., & He, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1005312 · Cited by 79
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
Iacono, O. L., Venezia, G., Petta, S., Mineo, C., LISI, S. D., Marco, V. D., Rodolico, V., Amato, M. C., Ferraro, D., Giordano, C. S. D. S., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03309.x · Cited by 79
Effect of Pioglitazone Therapy on Myocardial and Hepatic Steatosis in Insulin-Treated Patients with Type 2 Diabetes
Zib, I., Jacob, A. N., Lingvay, I., Salinas, K., McGavock, J., Raskin, P., & Szczepaniak, L. S. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.00003 · Cited by 79
Molecular Interactions between NAFLD and Xenobiotic Metabolism
Naik, A., Belič, A., Zanger, U. M., & Rozman, D. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00002 · Cited by 79
Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity
Cai, Y., Li, H., Liu, M., Pei, Y., Zheng, J., Zhou, J., Luo, X., Huang, W., Ma, L., Yang, Q., et al. (2018) · Hepatology · doi:10.1002/hep.29777 · Cited by 79
Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms
Yan, Z., Fan, R., Yin, S., Zhao, X., Liu, J., Li, L., Zhang, W., & Ge, L. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.05.054 · Cited by 79
Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice
Tanaka, N., Zhang, X., Sugiyama, E., Kono, H., Horiuchi, A., Nakajima, T., Kanbe, H., Tanaka, E., Gonzalez, F. J., & Aoyama, T. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.031 · Cited by 78
Inhibition of Acyl-Coenzyme A:Cholesterol Acyltransferase 2 (ACAT2) Prevents Dietary Cholesterol-associated Steatosis by Enhancing Hepatic Triglyceride Mobilization
Alger, H. M., Brown, J. M., Sawyer, J. K., Kelley, K. L., Shah, R., Wilson, M. D., Willingham, M. C., & Rudel, L. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118422 · Cited by 78
Effects of açai on oxidative stress, ER stress, and inflammation-related parameters in mice with high fat diet-fed induced NAFLD
Carvalho, M. M. D. F., Lage, N. N., Paulino, A. H. D. S., Pereira, R. R., Almeida, L. T., da Silva, T. F., Magalhães, C. L. D. B., de Lima, W. G., Silva, M. E., Pedrosa, M. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44563-y · Cited by 78
The Expression of NAD(P)H:Quinone Oxidoreductase 1 Is High in Human Adipose Tissue, Reduced by Weight Loss, and Correlates with Adiposity, Insulin Sensitivity, and Markers of Liver Dysfunction
Palming, J., Sjöholm, K., Jernås, M., Lystig, T., Gummesson, A., Romeo, S., Lönn, L., Lönn, M., Carlsson, B., & Carlsson, L. M. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2476 · Cited by 78
Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes
Chung, M., Park, H. J., Manautou, J. E., Koo, S. I., & Bruno, R. S. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.01.001 · Cited by 78
Type 2 Diabetes Mellitus and the Risk of Hepatitis C Virus Infection: A systematic review
Guo, X., Jin, M., Yang, M. J., Liu, K., & Lǐ, J. (2013) · Scientific Reports · doi:10.1038/srep02981 · Cited by 78
A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats
Buqué, X., Martínez, M. J., Cano, A., Miquilena-Colina, M. E., García‐Monzón, C., Aspichueta, P., & Ochoa, B. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m001966 · Cited by 78
Long-Chain Monounsaturated Fatty Acids and Incidence of Congestive Heart Failure in 2 Prospective Cohorts
Imamura, F., Lemaître, R. N., King, I. B., Song, X., Steffen, L. M., Folsom, A. R., Siscovick, D. S., & Mozaffarian, D. (2013) · Circulation · doi:10.1161/circulationaha.112.001197 · Cited by 78
Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis
Go, Y., Jeong, J. Y., Jeoung, N. H., Jeon, J., Park, B.-Y., Kang, H., Ha, C., Choi, Y., Lee, S. J., Ham, H. J., et al. (2016) · Diabetes · doi:10.2337/db16-0223 · Cited by 78
Development of Nonalcoholic Hepatopathy: Contributions of Oxidative Stress and Advanced Glycation End Products
Santos, J. C., Valentim, I. B., de Araújo, O. R. P., Ataíde, T. D. R., & Goulart, M. O. F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019846 · Cited by 77
Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
Yang, S. J., Choi, J. M., Chae, S. W., Kim, W. J., Park, S. E., Rhee, E., Lee, W., Oh, K. W., Park, S. W., Kim, S. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017057 · Cited by 77
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
Loria, P., Lonardo, A., Bellentani, S., Day, C., Marchesini, G., & Carulli, N. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.007 · Cited by 77
Opuntia ficus indica (Nopal) Attenuates Hepatic Steatosis and Oxidative Stress in Obese Zucker (fa/fa) Rats3
Morán‐Ramos, S., Ávila-Nava, A., Tovar, A. R., Pedraza‐Chaverrí, J., López‐Romero, P., & Torres, N. (2012) · Journal of Nutrition · doi:10.3945/jn.112.165563 · Cited by 77
Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study
Gylling, H., Hallikainen, M., Pihlajamäki, J., Simonen, P. P., Kuusisto, J., Laakso, M., & Miettinen, T. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p006619 · Cited by 77
Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression
Kaltenecker, D., Themanns, M., Mueller, K. M., Spirk, K., Suske, T., Merkel, O., Kenner, L., Luís, A., Kozlov, A. V., Haybaeck, J., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.10.010 · Cited by 76
Nonalcoholic Fatty Liver Disease in Prepubertal Children Born Small for Gestational Age: Influence of Rapid Weight Catch-Up Growth
Faienza, M. F., Brunetti, G., Ventura, A., D’Aniello, M., Pepe, T., Giordano, P., Monteduro, M., & Cavallo, L. (2013) · Hormone Research in Paediatrics · doi:10.1159/000347217 · Cited by 76
Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli, P., Obregón, A. M., & Videla, L. A. (2011) · PubMed · doi:10.1590/s0212-16112011000300003 · Cited by 76
Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease: Is the Liver Another Target?
Mirrakhimov, A. E., & Polotsky, V. Y. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00149 · Cited by 76
Treatment with oligonol, a low-molecular polyphenol derived from lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid metabolism
Noh, J. S., Park, C. H., & Yokozawa, T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511001322 · Cited by 76
Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis
Pak, W., Takayama, F., Mine, M., Nakamoto, K., Kodo, Y., Mankura, M., Egashira, T., Kawasaki, H., & Mori, A. (2012) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.12-18 · Cited by 75
HIV-1 Vpr Induces Adipose Dysfunction in Vivo Through Reciprocal Effects on PPAR/GR Co-Regulation
Agarwal, N., Iyer, D., Patel, S. G., Sekhar, R. V., Phillips, T. M., Schubert, U., Oplt, T., Buras, E. D., Samson, S. L., Couturier, J. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007148 · Cited by 75
Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine
Kalhan, S. C., Edmison, J. M., Marczewski, S., Dasarathy, S., Gruca, L. L., Bennett, C. D., Duenas, C., & López, R. (2011) · Clinical Science · doi:10.1042/cs20110060 · Cited by 75
SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells
Shi, T., Fan, G. Q., & Shu Dong, X. I. A. O. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00416.x · Cited by 75
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
Yoon, H. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i11.800 · Cited by 75
Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet
Xu, L. L., Huang, D., Hu, Q., Wu, J., Wang, Y., & Feng, J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001130 · Cited by 75
Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation
Maehara, N., Arai, S., Mori, M., Iwamura, Y., Kurokawa, J., Kai, T., Kusunoki, S., Taniguchi, K., Ikeda, K., Ohara, O., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.058 · Cited by 74
Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice
Guo, F., Ma, Y., Kadegowda, A. K. G., Betters, J. L., Xie, P., Liu, C., Liu, X., Miao, H., Ou, J., Su, X., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035519 · Cited by 74
Dynamic Regulation of Hepatic Lipid Droplet Properties by Diet
Crunk, A. E., Monks, J., Murakami, A., Jackman, M. R., MacLean, P. S., Ladinsky, M. S., Bales, E. S., Cain, S., Orlicky, D. J., & McManaman, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067631 · Cited by 74
Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice
Jung, U. J., Baek, N., Chung, H., Bang, M., Jeong, T., Lee, K., Kang, Y.-J., Lee, M., Kim, H., Yeo, J., et al. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.09.009 · Cited by 74
Physiological role of adiponectin in different tissues: a review
Esmaili, S., Hemmati, M., & Karamian, M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1493606 · Cited by 73
Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis
Jia, L., Ma, Y., Rong, S., Betters, J. L., Xie, P., Chung, S., Wang, N., Tang, W., & Yu, L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006353 · Cited by 73
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Dongiovanni, P., Paolini, E., Corsini, A., Sirtori, C. R., & Ruscica, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13519 · Cited by 73
In vitro/vivostudies towards mechanisms of risperidone-induced oxidative stress and the protective role of coenzyme Q10 and N-acetylcysteine
Eftekhari, A., Ahmadian, E., Azarmi, Y., Parvizpur, A., Hamishehkar, H., & Eghbal, M. A. (2016) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2016.1204641 · Cited by 72
Effect of peroxisome proliferator‐activated receptors‐γ and co‐activator‐1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non‐alcoholic fatty liver disease in Chinese people
Hui, Y., Li, Y., Yu‐Qiang, N., Wei‐Hong, S., Du, Y., Xiao-bo, L., & Yong-jian, Z. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01623.x · Cited by 72
Nonalcoholic Fatty Liver Disease
Paredes, A. H., Torres, D. M., & Harrison, S. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.005 · Cited by 72
Med25 Is Required for RNA Polymerase II Recruitment to Specific Promoters, Thus Regulating Xenobiotic and Lipid Metabolism in Human Liver
Rana, R., Surapureddi, S., Kam, W., Ferguson, S., & Goldstein, J. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00847-10 · Cited by 72
Reduced delivery of epididymal adipocyte‐derived exosomal resistin is essential for melatonin ameliorating hepatic steatosis in mice
Rong, B., Feng, R., Liu, C., Wu, Q., & Sun, C. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12561 · Cited by 72
Lipid Accumulation and Insulin Resistance: Bridging Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease
Cao, X., Wang, N., Yang, M. J., & Zhang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146962 · Cited by 71
Role of Mitochondria in Alcoholic Liver Disease
García‐Ruiz, C., Kaplowitz, N., & Fernández-Checa, J. C. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0021-z · Cited by 71
Hepatic Steatosis and Peroxisomal Fatty Acid Beta-oxidation
Cherkaoui‐Malki, M., Surapureddi, S., Hajj, H. I. E., Vamecq, J., & Andreoletti, P. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762765 · Cited by 71
Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway
Kudo, Y., Tanaka, Y., Tateishi, K., Yamamoto, K., Yamamoto, S., Mohri, D., Isomura, Y., Seto, M., Nakagawa, H., Asaoka, Y., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.025 · Cited by 71
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice
Singhal, N. S., Patel, R. T., Qi, Y., Lee, Y.-S., & Ahima, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2007 · Cited by 71
Redox Regulation of Store-Operated Ca 2+ Entry
Nunes, P., & Demaurex, N. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5615 · Cited by 70
Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice
Wang, Q. A., Li, S., Jiang, L., Zhou, Y., Li, Z., Shao, M., Li, W., & Liu, Y. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003335 · Cited by 70
Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients.
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2010) · PubMed · Cited by 70
Aging Increases Susceptibility to High Fat Diet‐Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy
Nunes-Souza, V., César-Gomes, C. J., da Fonseca, L. J. S., Guedes, G. D. S., Smaniotto, S., & Rabelo, L. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1987960 · Cited by 70
Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1
Cheng, B., Gao, W., Wu, X., Zheng, M., Yu, Y., Song, C., Miao, W., Yang, Z., He, Y., Liu, C., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00833 · Cited by 69
The influence of PM2.5 exposure on non-alcoholic fatty liver disease
Chen, J., Wu, L., Yang, G., Zhang, C., Liu, X., Sun, X., Chen, X., & Wang, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119135 · Cited by 70
Uncoupling protein-2 and non-alcoholic fatty liver disease
Baffy, G. (2005) · Frontiers in bioscience · doi:10.2741/1683 · Cited by 69
Impact of New-Generation Lipid Emulsions on Cellular Mechanisms of Parenteral Nutrition–Associated Liver Disease
Burrin, D. G., Ng, K., Stoll, B., & de Pipaón, M. S. (2014) · Advances in Nutrition · doi:10.3945/an.113.004796 · Cited by 69
Changes in adipocyte cell size, gene expression of lipid metabolism markers, and lipolytic responses induced by dietary fish oil replacement in gilthead sea bream (Sparus aurata L.)
Cruz-Garcia, L., Sánchez-Gurmaches, J., Bouraoui, L., Saera-Vila, A., Pérez‐Sánchez, J., Gutiérrez, J., & Navarro, I. (2010) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2010.11.024 · Cited by 69
Aqueous extracts of hulled barley containing coumaric acid and ferulic acid inhibit adipogenesis in vitro and obesity in vivo
Seo, C. R., Yi, B. R., Oh, S., Kwon, S.-M., Kim, S., Song, N. J., Cho, J. Y., Park, K. M., Ahn, J.-Y., Hong, J., et al. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.11.022 · Cited by 69
Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation
Makia, N. L., Bojang, P., Falkner, K. C., Conklin, D. J., & Prough, R. A. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.013 · Cited by 69
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
Suzuki‐Kemuriyama, N., Matsuzaka, T., Kuba, M., Ohno, H., Han, S., Takeuchi, Y., Isaka, M., Kobayashi, K., IWASAKI, H. O., Yatoh, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157580 · Cited by 69
High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men
Lee, J.-E., Yoon, K., Ryu, S., Chang, Y., & Kim, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172666 · Cited by 69
Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells
Sun, Y., Yuan, X., Zhang, F., Han, Y., Chang, X., Xu, X., Li, Y., & Gao, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-11860-3 · Cited by 69
An HDAC3-PROX1 corepressor module acts on HNF4α to control hepatic triglycerides
Armour, S. M., Remsberg, J. R., Damle, M., Sidoli, S., Ho, W. Y., Li, Z., Garcia, B. A., & Lazar, M. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00772-5 · Cited by 69
High fat diet‐induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice
Yu, D., Chen, G., Pan, M., Zhang, J., He, W., Liu, Y., Nian, X., Sheng, L., & Xu, B. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26270 · Cited by 69
Inorganic arsenic causes fatty liver and interacts with ethanol to cause alcoholic liver disease in zebrafish
Bambino, K., Zhang, C., Austin, C. E., Amarasiriwardena, C. J., Arora, M., Chu, J., & Sadler, K. C. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.031575 · Cited by 70
The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Hliwa, A., Ramos‐Molina, B., Łaski, D., Mika, A., & Śledziński, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136900 · Cited by 68
Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2
Bathish, B., Robertson, H., Dillon, J. F., Dinkova‐Kostova, A. T., & Hayes, J. D. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.226 · Cited by 70
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
Aller, R., de Luis, D. A., Izaola, O., Sagrado, M. G., Conde, R., Velasco, M. C., Alvarez, T., Pacheco, D., & González, J. M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0539-9 · Cited by 68
Effect of Chenodeoxycholic Acid on Fibrosis, Inflammation and Oxidative Stress in Kidney in High-Fructose-Fed Wistar Rats
Hu, Z., Ren, L., Wang, C., Liu, B., & Song, G. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000341485 · Cited by 68
Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease
Lin, Z., Cai, F., LIN, N., YE, J., Zheng, Q., & Ding, G.-S. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1434 · Cited by 68
Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death: Introduction to a Thematic Review Series
Schaffer, J. E. (2016) · Journal of Lipid Research · doi:10.1194/jlr.e069880 · Cited by 68
Rhein protects against cerebral ischemic‑/reperfusion‑induced oxidative stress and apoptosis in rats
Zhao, Q., Wang, X., Chen, A., Cheng, X., Zhang, G., Sun, J., Zhao, Y., Huang, Y., & Zhu, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3488 · Cited by 68
Mitochondrial Reactive Oxygen Species Signal Hepatocyte Steatosis by Regulating the Phosphatidylinositol 3-Kinase Cell Survival Pathway
Kohli, R., Pan, X., Malladi, P., Wainwright, M. S., & Whitington, P. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701759200 · Cited by 67
Herbal medicines for fatty liver diseases
Liu, Z. L., Xie, L. Z., Zhu, J., Li, G. Q., Grant, S., & Liu, J. P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009059.pub2 · Cited by 67
Binge Alcohol–Induced Microvesicular Liver Steatosis and Injury are Associated with Down‐Regulation of Hepatic Hdac 1, 7, 9, 10, 11 and Up‐Regulation of Hdac 3
Kirpich, I., Ghare, S. S., Zhang, J., Gobejishvili, L., Kharebava, G., Joshi‐Barve, S., Barker, D. F., Moghe, A., McClain, C. J., & Barve, S. S. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01751.x · Cited by 67
High molecular weight persimmon tannin is a potent hypolipidemic in high-cholesterol diet fed rats
Zou, B., Li, C., Chen, J., Dong, X., Zhang, Y., & Du, J. (2012) · Food Research International · doi:10.1016/j.foodres.2012.05.024 · Cited by 67
Lipoprotein Lipase Expression in Livers of Morbidly Obese Patients Could be Responsible for Liver Steatosis
Pardina, E., Baena‐Fustegueras, J. A., Llamas, R., Catalán, R., Galard, R., Lecube, A., Fort, J. M., Llobera, M., Allende, H., Vargas, V., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9827-5 · Cited by 67
Mouse KLF11 regulates hepatic lipid metabolism
Zhang, H., Chen, Q., Yang, M. H., Zhu, B., Cui, Y., Xue, Y., Gong, N., Cui, A., Wang, M., Shen, L., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.024 · Cited by 67
Experimental Periodontitis Induces Gene Expression of Proinflammatory Cytokines in Liver and White Adipose Tissues in Obesity
Endo, Y., Tomofuji, T., Ekuni, D., Irie, K., Azuma, T., Tamaki, N., Yamamoto, T., & Morita, M. (2010) · Journal of Periodontology · doi:10.1902/jop.2009.090574 · Cited by 67
Perforin Is a Novel Immune Regulator of Obesity-Related Insulin Resistance
Revelo, X. S., Tsai, S. J., Lei, H., Luck, H., Ghazarian, M., Tsui, H., Shi, S. Y., Schroer, S. A., Luk, C. T., Lin, G. H. Y., et al. (2014) · Diabetes · doi:10.2337/db13-1524 · Cited by 68
Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
Buechler, C., & Weiß, T. S. (2011) · Current Drug Metabolism · doi:10.2174/138920011794520035 · Cited by 67
Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J. L., Vacca, M., & Vidal‐Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 67
FOXO transcription factors protect against the diet-induced fatty liver disease
Pan, X., Zhang, Y., Kim, H.-G., Liangpunsakul, S., & Dong, X. C. (2017) · Scientific Reports · doi:10.1038/srep44597 · Cited by 67
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review)
Kawaratani, H., Moriya, K., Namisaki, T., Uejima, M., Kitade, M., Takeda, K., Okura, Y., Kaji, K., Takaya, H., Nishimura, N., et al. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3015 · Cited by 67
Disrupted galectin‐3 causes non‐alcoholic fatty liver disease in male mice
Nomoto, K., Tsuneyama, K., Aziz, H. A., Takahashi, H., Murai, Y., Cui, Z., Fujimoto, M., Kato, I., Hiraga, K., Hsu, D., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2065 · Cited by 67
Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Wang, X., Rao, H., Liu, F., Wei, L., Li, H., & Wu, C. (2021) · Cells · doi:10.3390/cells10123300 · Cited by 66
Oxidative stress induces the endoplasmic reticulum stress and facilitates inclusion formation in cultured cells
Hanada, S., Harada, M., Kumemura, H., Omary, M. B., Koga, H., Kawaguchi, T., Taniguchi, E., Yoshida, T., Hisamoto, T., Yanagimoto, C., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.039 · Cited by 66
Eugenol Ameliorates Hepatic Steatosis and Fibrosis by Down-Regulating SREBP1 Gene Expression via AMPK-mTOR-p70S6K Signaling Pathway
Jo, H. K., Kim, G. W., Jeong, K. J., Kim, D. Y., & Chung, S. H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00281 · Cited by 66
Endoplasmic Reticulum Stress Plays a Key Role in Rotenone-Induced Apoptotic Death of Neurons
Goswami, P., Gupta, S., Biswas, J., Joshi, N., Swarnkar, S., Nath, C., & Singh, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9001-5 · Cited by 66
Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease
Papandreou, D., Karabouta, Z., Pantoleon, A., & Rousso, I. (2012) · Appetite · doi:10.1016/j.appet.2012.09.006 · Cited by 66
Adipose tissue oxygen tension
Goossens, G. H., & Blaak, E. E. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328358fa87 · Cited by 66
Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammation
Górnicka, A., Fettig, J., Eguchi, A., Berk, M. P., Thapaliya, S., Dixon, L. J., & Feldstein, A. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2012 · Cited by 68
Analysis ofN-glycan in serum glycoproteins fromdb/dbmice and humans with type 2 diabetes
Itoh, N., Sakaue, S., Nakagawa, H., Kurogochi, M., Ohira, H., Deguchi, K., Nishimura, S., & Nishimura, M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00182.2007 · Cited by 66
Salt-inducible Kinase Regulates Hepatic Lipogenesis by Controlling SREBP-1c Phosphorylation
Yoon, Y.-S., Seo, W., Lee, M., Kim, S., & Koo, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900096200 · Cited by 66
Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth Retardation
He, J., Li, D., Xu, W. H., Bai, K., Lu, C., Wu, Y., Huang, Q., Zhang, L., & Wang, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136848 · Cited by 66
Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model
Braud, L., Battault, S., Meyer, G., do Nascimento, A. R., Gaillard, S., de Sousa, G., Rahmani, R., Riva, C., Armand, M., Maixent, J. M., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.012 · Cited by 66

Authors: Browning, J. D., & Horton, J. D.
Affiliations: The University of Texas Southwestern Medical Center (US)
Corresponding author: Horton, Jay D.
ORCID: Horton, Jay D.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 147-152
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200422422
PMC: PMC449757
OpenAlex: W4230280576
Cited by: 1,772
References: 82
Citations by year: 2026: 18 · 2025: 32 · 2024: 45 · 2023: 50 · 2022: 73 · 2021: 72 · 2020: 75 · 2019: 100 · 2018: 104 · 2017: 89 · 2016: 102 · 2015: 109 · 2014: 90 · 2013: 104 · 2012: 103
FWCI: 48.64
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
Funders: American Liver Foundation
National Institutes of Health (HL20948)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: hepatic steatosis, liver injury, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, molecular mediators, lipid metabolism, reactive oxygen species, oxidative stress, mitochondrial dysfunction, lipid peroxidation, acetyl-CoA carboxylase, AMPK, ChREBP, stearoyl-CoA desaturase, polyunsaturated fatty acids, malondialdehyde

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mediators of hepatic steatosis and liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks